• Harmony Biosciences initial Form 3 shows interim principal financial officer Stephen M. Mollichella holding 2,506 common shares.
• Filing also lists stock options for 48,472 shares, exercise prices from $30.69 to $38.01.
• Restricted stock units total 12,013 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002146210-26-000002), on July 22, 2026, and is solely responsible for the information contained therein.